These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical use of cyclocarbothiamine (CCT) for neurogenic bladder dysfunction]. Nihira H, Kuze M, Kashiwagi T, Okita J, Tajiri K. Hinyokika Kiyo; 1966 Aug; 12(8):823-31. PubMed ID: 6008784 [No Abstract] [Full Text] [Related]
3. [Therapeutic effect of Robaveron tablet (KN-7) on neurogenic bladder]. Endo H, Sonoda T, Koyanagi T, Maru A, Kuroda K, Takamura T, Inada F, Rokuzyo M, Ohori T, Kubo T. Hinyokika Kiyo; 1984 Jan; 30(1):135-44. PubMed ID: 6375318 [Abstract] [Full Text] [Related]
4. [Clinical use of BuTDS in urological field]. Tanaka H, Mizoguchi M, Fujimoto Y, Ishibe T. Hinyokika Kiyo; 1966 Aug; 12(8):811-22. PubMed ID: 6008783 [No Abstract] [Full Text] [Related]
5. [Efficacy of repeat injections of botulinum A toxin to the detrusor in neurogenic bladder overactivity]. Chenet A, Perrouin-Verbe B, Le Normand L, Labat JJ, Brunel P, Lefort M, Mathé JF. Ann Readapt Med Phys; 2007 Nov; 50(8):651-60. PubMed ID: 17490775 [Abstract] [Full Text] [Related]
6. Nocturnal enuresis Electroencephalographic and cystometric examinations. Kajtor F, Ováry I, Zsadányi O. Acta Med Acad Sci Hung; 1967 Nov; 23(2):153-68. PubMed ID: 6047586 [No Abstract] [Full Text] [Related]
7. [Neuropathy with non-alcoholic thiamine deficiency: two cases of bladder disorders]. Mazevet D, Vassilev K, Perrigot M. Ann Readapt Med Phys; 2005 Feb; 48(1):43-7. PubMed ID: 15664684 [Abstract] [Full Text] [Related]
8. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity. Reitz A, Denys P, Fermanian C, Schurch B, Comperat E, Chartier-Kastler E. Eur Urol; 2007 Dec; 52(6):1729-35. PubMed ID: 17884281 [Abstract] [Full Text] [Related]
10. [Biochemical analysis of the effect of active vitamin B1, TTFD, on the neurogenic bladder]. Imabayashi K. Hinyokika Kiyo; 1966 Sep; 12(9):977-84. PubMed ID: 6009226 [No Abstract] [Full Text] [Related]
11. Cystometric study and urethral resistance measurements in cases of neurogenic bladder. Kaswan HS, Batra SC, Dandia SD. J Indian Med Assoc; 1982 Oct 01; 79(7):89-92. PubMed ID: 7166653 [No Abstract] [Full Text] [Related]
12. [Urodynamic study in neurogenic bladder. I. Cystomanometry]. Gallego Gómez J, Jiménez Cruz JF, Martínez Agullo E, Mompo Sanchis JA, Valls Blasco F, Boronat Tormo F. Arch Esp Urol; 1984 Oct 01; 37(2):135-50. PubMed ID: 6465962 [No Abstract] [Full Text] [Related]
13. Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study. Stöhrer M, Mürtz G, Kramer G, Schnabel F, Arnold EP, Wyndaele JJ, Propiverine Investigator Group. Eur Urol; 2007 Jan 01; 51(1):235-42. PubMed ID: 16698176 [Abstract] [Full Text] [Related]
17. [Cystomanometric evaluation of the decontracturing effect of a new synthetic antispastic agent (Flavoxate) on the neurogenic bladder]. Arduini M, Natili G. Minerva Urol; 1969 Jan 01; 21(4):127-31. PubMed ID: 4910989 [No Abstract] [Full Text] [Related]
19. [Comparative double-blind trial of KN-7 tablet and Robaveron injection in the treatment of neurogenic bladder]. Sonoda T, Endo H, Kuroda K, Takamura T, Inada F, Ohori T, Kubo T, Suzuki Y, Nakano N, Sato S. Hinyokika Kiyo; 1984 Apr 01; 30(4):561-79. PubMed ID: 6385666 [Abstract] [Full Text] [Related]
20. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. Akbar M, Abel R, Seyler TM, Bedke J, Haferkamp A, Gerner HJ, Möhring K. BJU Int; 2007 Sep 01; 100(3):639-45. PubMed ID: 17532858 [Abstract] [Full Text] [Related] Page: [Next] [New Search]